Technology Transfer

This report examines the role played by IPRs in both upstream and downstream phases of the research, development and commercialization of biotechnology products and provides a review and analysis of the existing body of knowledge concerning the role of IPRs.

Successful multi-sector global health programs engage partners and policymakers early, communicate openly and frequently with relevant stakeholders, and empower and involve communities, according to a website relaunched this week, Case Studies for Global Health.

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have collaborated on a new report that builds upon the findings in BVGH’s previous analysis, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape.

While the U.S. leads in the area of biotechnology, there is no guarantee this competitive edge will continue.

The purpose of this survey was to examine technology transfer and licensing practices by biotechnology companies and determine its importance to the industry.

The purpose of this survey was to examine the extent and importance of technology transfer and licensing activity involving biotechnology companies.

The study provides first-of-its-kind data on the importance of university/industry research and development partnerships to the U.S. economy.

This side-event, organized by the Biotechnology Industry Organization (BIO) and cosponsored by the Association of University Technology Managers (AUTM), provided an overview on the key elements at play in establishment an enabling environment for transfer of technology to support the full implementation of CBD objectives and priorities.

June 19 2013
The TTIP represents a profoundly important opportunity to advance progress in these areas. The following comments represent BIO’s initial suggestions for the formulation of negotiating objectives relevant to biotechnology.  
June 19 2013
We understand the challenges that India faces with respect to healthcare and the innovative biotechnology industry stands ready to work with India to help address them.  
February 14 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
April 7 2011
The House Subcommittee on Healthcare and Technology held a hearing on The Creating Jobs Through Small Business Innovation Act of 2011, a bill that would reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help fund small innovative companies on the brink of new technologies and discoveries.
May 27 2010
The paper highlights factors that contribute to enabling environments for promising technologies to gain access to early capital.
June 6 2011
The United States Supreme Court issued it's opinion on the appeal of Stanford University against Roche Diagnostics, which is of significant importance because of its potential impact on university technology transfer, development and commercialization of university-generated basic technology and scientific collaborations between university and private-sector scientists.
April 7 2011
Today, the House Subcommittee on Healthcare and Technology will hold a hearing on The Creating Jobs Through Small Business Innovation Act of 2011, a bill that would reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which help fund small innovative companies on the brink of new technologies and discoveries.
July 30 2008
Small businesses that are majority-backed by venture capital, many of which are producing biotech therapies and cures, will be eligible for a portion of Small Business Innovation Research (SBIR) grants under a bill reported out of the Senate Committee on Small Business today. The bill reauthorizes the SBIR program for 14 years.
September 20 2006
The Milken Institute study released today entitled “Mind-to-Market: A Global Analysis of University Biotechnology Technology Transfer and Commercialization” reaffirms the critical role of technology transfer in the development of the biotechnology industry worldwide, said Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood.
May 30 2002
The Biotechnology Industry Organization’s (BIO) annual meeting, BIO 2002 in Toronto, will feature a Technology Transfer Forum that will bring science and business together to speed commercialization of basic technology into useful consumer products.